LRRK2 and Lipid Pathways: Implications for Parkinson's Disease

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Genetic alterations in the leucine-rich repeat kinase 2 (LRRK2) gene are a significant risk factor for Parkinson's disease (PD).
• Emerging evidence implicates LRRK2 in lipid metabolism and signaling pathways, crucial for cellular function.
• LRRK2's interaction with lipid-associated proteins and its role in regulating enzymes involved in lipid catabolism are increasingly recognized.

Purpose of the Study:

• To review and summarize the current evidence linking LRRK2 to various lipid pathways.
• To discuss the functional consequences of LRRK2-associated lipid alterations in the context of Parkinson's disease.

Main Methods:

• Literature review of studies investigating LRRK2, lipid metabolism, and Parkinson's disease.
• Analysis of findings from genetic studies, knockout models, and human mutation carriers.

Main Results:

• LRRK2 interacts with lipid-binding proteins and influences Rab GTPases involved in lipid transport and storage.
• LRRK2 modulates the activity of enzymes critical for plasma membrane and lysosomal lipid breakdown.
• Alterations in sterols, sphingolipids, phospholipids, fatty acyls, and glycerolipids are observed in LRRK2 knockout models and human mutation carriers across various tissues.

Conclusions:

• LRRK2 plays a multifaceted role in regulating lipid homeostasis, extending beyond its kinase activity.
• Dysregulation of lipid pathways by altered LRRK2 function represents a key mechanism contributing to Parkinson's disease pathology.
• Targeting LRRK2-mediated lipid dysregulation may offer novel therapeutic strategies for Parkinson's disease.